PAMF Fertility Success Rates

At PAMF, we’re proud of our outcomes because we work with you and each individual patient to determine the right treatment, no matter how it might affect our “success” numbers. That means:

We won’t exclude you based on preliminary test results.
We often recommend simpler, less expensive treatments before advanced treatments such as in vitro fertilization, and many conceive and have a baby without IVF.
We give you all relevant treatment options, along with clear information about each option’s possibility of success, instead of directing you to specific treatments based only on prognosis.
We partner with you to determine the best treatment route. If you prefer to first try a particular treatment option, knowing there is a limited chance of success, we will honor that preference assuming it is medically safe and appropriate. Examples include trying intrauterine insemination before IVF, or using your own eggs instead of donor eggs.

Live Birth and Full Term Pregnancy Rates

Following SART guidelines, our 2018 data shows “Live Birth” rates for all cycles initiated, instead of “Pregnancy” or “Clinical Pregnancy” rates, which do not include live birth results.

PAMF Outcomes 2018 and 2019 as reported to CDC and SART

Cumulative Live Birth Rates per Initiated Cycle

Age	<35	35-37	38-40	41-42
PAMF Final 2018	63.50%	44.40%	44.90%	12.20%
US National Final 2018	55.60%	40.80%	26.80%	13.40%
PAMF Preliminary 2019	54.10%	35.60%	21.30%	9.80%
US National Preliminary 2019*	46.70%	34.20%	21.60%	10.60%

*National 2019 final data pending

Full Term Pregnancy Rates

Age	<35	35-37	38-40	41-42
PAMF Final 2018	87.70%	89.60%	83.60%	3 of 6
US National Final 2018	83.80%	83.70%	83.60%	85.70%
PAMF Preliminary 2019	98.10%	80.60%	87.00%	4 of 5
US National Preliminary 2019*	85.20%	85.70%	84.80%	85.30%

*National 2019 final data pending

PAMF Current (January 2020 – March 2021) Clinical Pregnancy Rates per Embryo Transfer

Age	All Ages	<35	35-37	38-40	41-42
Fresh Embryos	59.30% (n=84)	61.40% (n=40)	60.00% (n=27)	40.00% (n=10)	1 of 3 (n=3)
Frozen Embryos	58.00% (n=308)	61.90% (n=90)	60.40% (n=94)	56.30% (n=84)	56.50% (n=84)

SART Guidelines in Reporting Treatment Outcomes

We are members of and follow guidelines set forth by the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (SART), as well as other organizations setting standards of excellence for fertility treatment.

As a participating SART member, we report our treatment outcomes to the Centers for Disease Control and Prevention (CDC), which collects and reports on assisted reproductive technology (ART) clinic success rates.

SART provides helpful information on how to interpret success rates.

Per SART recommendations, it’s important to note that a comparison of clinic success rates may not be meaningful because patient characteristics and treatment approaches may vary from clinic to clinic.